TABLE 2.
Cardiovascular Diagnostics and Therapeutics Among Critically Ill Adults With Sepsis and Elevated Troponin I
| Cardiovascular Management Approach | Sepsis With Elevated Troponin I |
|---|---|
| Total, n (%) | 27,665 (100) |
| Cardiovascular diagnostic testing | |
| Hospital day of first elevated troponin I, median (IQR) | 1 (1–1) |
| First elevated troponin I level (ng/mL), median (IQR) | 0.14 (0.07–0.47) |
| Hospital day of maximum troponin I level, median (IQR) | 1 (1–2) |
| Maximum troponin I level (ng/mL), median (IQR) | 0.28 (0.09–1.30) |
| Serial troponin I, n (%) | 23,447 (84.8) |
| Number of serial troponin I measurements after the first elevated troponin I, median (IQR) | 2 (1–3) |
| Trend troponin I to peak, n (%) | 18,255 (66.0) |
| Echocardiography, n (%) | 18,455 (66.7) |
| Cardiac stress test, n (%) | 1,128 (4.1) |
| Cardiac catheterization, n (%) | 1,829 (6.6) |
| Cardiovascular therapeutics, n (%) | |
| Antiplatelet agents, n (%) | 13,349 (48.3) |
| Therapeutic anticoagulation, n (%) | 2,293 (8.3) |
| Beta-blockers, n (%) | 13,967 (50.5) |
| Statins, n (%) | 10,541 (38.1) |
IQR = interquartile range.